pancreatitis glp 1 symptoms Updates in Medicine | GLP-1s may raise risk early—but over time, protective effects balance the scale, resulting in no increase in overall 1-year risk Pancreatitis Risk Associated with GLP-1

Yazens digital weight loss programme shows 61% GLP-1 adherence at 18 months highlighting the power of integrated medical and lifestyle support

A new class action lawsuit alleges Hims & Hers falsely advertises its compounded GLP-1 semaglutide products as being the same as the weight loss and diabetes drugs Ozempic and Wegovy.

Arrowhead Health offers doctor-guided semaglutide injections for safe, effective weight loss

On Tuesday, March 3, 2026, the Centers for Medicare and Medicaid Services (CMS) released Frequently Asked Questions (FAQs) (which he...

The two incretin peptides that enable this effect are the glucose-dependent insulinotropic polypeptide (GIP) and the glucagon-like peptide 1 (GLP-1), which ...

Summary Clinical studies highlight that GLP-1RA to treat obesity, alongside their concomitant cardioprotective effects, have become a hallmark in clinical science.